Common cardiovascular medication ineffective for majority of British South Asians
A new genetic study has found that cardiovascular medication used to prevent heart attacks is much less likely to benefit people of Bangladeshi and Pakistani ancestry than people of European descent. Scientists at Queen Mary University in London discovered that clopidogrel, a commonly prescribed medication used to prevent further heart attacks after an initial event,... Read moreThe post Common cardiovascular medication ineffective for majority of British South Asians appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - August 24, 2023 Category: Nursing Authors: Carolyn Scott Tags: Cardiology Health inequality Source Type: news
ASA Not Best Antiplatelet in Established CAD: Meta-Analysis ASA Not Best Antiplatelet in Established CAD: Meta-Analysis
Clopidogrel or ticagrelor may be safer and more effective than traditional aspirin for secondary prevention, suggests evidence from seven randomized trials.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 14, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Which Antiplatelet Agent for Patients With TIA and Obesity? Which Antiplatelet Agent for Patients With TIA and Obesity?
Ticagrelor plus aspirin was associated with a lower risk for recurrent stroke than clopidogrel plus aspirin in patients with obesity who carry the CYP2C19 loss-of-function allele.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - July 12, 2023 Category: Primary Care Tags: Cardiology News Source Type: news
Ticagrelor May Reduce Brain Lesions After Carotid Stenting Ticagrelor May Reduce Brain Lesions After Carotid Stenting
The number and volume of emergent ischemic lesions following carotid artery stenting may be reduced with use of ticagrelor vs clopidogrel, secondary findings of the PRECISE-MRI trial suggest.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 13, 2023 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
P2Y12 Inhibitor Intensity De-escalation in Patients With ACS P2Y12 Inhibitor Intensity De-escalation in Patients With ACS
A new meta-analysis assesses a DAPT de-escalation strategy based on modulation of DAPT intensity by switching from potent P2Y12 receptor inhibitors to clopidogrel in patients with ACS.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Pharmacogenomics in Stroke and Cardiovascular Disease Pharmacogenomics in Stroke and Cardiovascular Disease
This review provides an overview of the genetic variants that influence individual responses to aspirin, clopidogrel, warfarin, and statins and the clinical implications for stroke patients.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Indobufen Noninferior to Aspirin for DAPT After PCI: OPTION Indobufen Noninferior to Aspirin for DAPT After PCI: OPTION
Antiplatelet agent indobufen was noninferior to aspirin in combination with clopidogrel after coronary intervention on both efficacy and safety outcomes, with less mostly minor bleeding.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 28, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Clopidogrel Recall; COAPT Score; Pediatric Cardiologist's Child Porn
(MedPage Today) -- FDA advised that generic lots of atenolol and clopidogrel (Plavix) are under recall due to a label mix-up by manufacturer Golden State Medical Supply.
LivaNova's LifeSPARC advanced circulatory support system has its controller... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 4, 2022 Category: Cardiology Source Type: news
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up
Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing Clopidogrel 75mg Tablets produced with lot# GS046745 was mislabeled as Atenolol 25mg Tablets. This (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 30, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCI
(MedPage Today) -- A shortened course of dual antiplatelet therapy (DAPT) after angioplasty was associated with reduced bleeding, with no significant uptick in ischemic events, over longer follow-up of the SMART-CHOICE trial.
Patients undergoing... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 29, 2022 Category: Cardiology Source Type: news
Full - Dose Anticoagulation Beneficial for Critically Ill With COVID - 19
However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 16, 2022 Category: Cancer & Oncology Tags: Cardiology, Infections, Internal Medicine, Critical Care, Oncology, Pharmacy, Conference News, Source Type: news
PANTHER: Should Clopidogrel Become the'New Aspirin' in CAD? PANTHER: Should Clopidogrel Become the'New Aspirin' in CAD?
The PANTHER meta-analysis of trials comparing aspirin with clopidogrel or ticagrelor as antiplatelet monotherapy in coronary artery disease patients suggest that P2Y12 inhibitor therapy is more effective.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 1, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
What to Know About Peripheral Artery Disease —and Its Connection to Diabetes
When we think of clogged arteries, most of us think about the heart. “But buildup of fatty plaques can happen in any artery, including those that carry blood away from the heart,” says Dr. Samuel Kim, a preventive cardiologist and lipidologist at Weill Cornell Medicine in New York.
The arteries that branch out and feed into our arms and legs make up the bulk of what we call peripheral arteries. And the narrowing in these vessels is referred to as peripheral artery disease (PAD), a common condition in which the legs or arms don’t receive sufficient blood flow. “Interestingly, arteries in our legs and...
Source: TIME: Health - August 11, 2022 Category: Consumer Health News Authors: Lala Tanmoy Das Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Drug pricing regulator NPPA fixes retail prices of 84 drug formulations
Similarly, the price of Paracetamol and Caffeine has been fixed at Rs 2.88 per tablet. Besides, the price of one Rosuvastatin Aspirin and Clopidogrel capsule has been fixed at Rs 13.91.In a separate notification, NPPA said it has extended the revised ceiling price of liquid medical oxygen and oxygen inhalation (medicinal gas) till September 30 this year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 3, 2022 Category: Pharmaceuticals Source Type: news
